Reevaluating the role of vascular changes in the differential diagnosis of Alzheimer's disease and vascular dementia

European Neurology

Volumn 40, Issue 3, 1998, Pages 121-129

  Gold, Gabriel ^a,b   Giannakopoulos, Panteleimon ^a   Bouras, Constantin ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b Hopital de Geriatrie   (Switzerland)

Author keywords

Alzheimer's disease; Clinical criteria; Neuroimaging; Neuropathology; Review; Risk factors; Vascular dementia

Indexed keywords

ALZHEIMER DISEASE; DEMENTIA; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; HUMAN; MULTIINFARCT DEMENTIA; NEUROPATHOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; PATHOLOGY; VISUAL CORTEX;

ALZHEIMER DISEASE; DEMENTIA, VASCULAR; DIAGNOSIS, DIFFERENTIAL; HUMANS; RISK FACTORS; VISUAL CORTEX;

EID: 0031593721     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007968     Document Type: Review

References (140)

1. Alzheimer A: Die arteriosklerotische Atrophie des Gehirns. Allg Z Psychiatr 1895;51:1809-1812.
2. Binswanger O: Die Abgrenzung der allgemeinen progressiven Paralyse. Berl Klin Wochenschr 1894;31:1103-1105, 1137-1139, 1180-1186.
3. Gorelick PB, Freels S, Harris Dollear BS, Billingsley BA, Brown N: Epidemiology of vascular and Alzheimer's dementia among African Americans in Chicago, IL. Neurology 1994;44: 1391-1396.
4. Rockwood K, Ebly E, Hachinski V, Hogan D: Presence and treatment of vascular risk factors in patients with vascular cognitive impairment. Arch Neurol 1997;54:33-39.
5. Meyer JS, McClintic K, Rogers RL Sims P, Mortel K: Aetiological considerations and risk factors for multi-infarct dementia. J Neurol Neurosurg Psychiatry 1988;51:1489-1497.
6. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, Persson G, Odén A, Svanborg A: 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347:1141-1144.
7. Babikian U, Ropper AH: Binswanger's disease: A review. Stroke 1987;18:2-12.
8. Lindsay J, Hebert R, Rockwood K: The Canadian Study of Health and Aging - Risk factors for vascular dementia. Stroke 1997;28:526-530.
9. Yoshitake T, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, Ohmori S, Nomiyama K, Kawano H, Ueda K, Suseishi K, Tsuneyoshi M, Fujishima M: Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama study. Neurology 1995;45: 1161-1168.
10. Rocca WA, Hofman A, Brayne C, Breteler MM, Clarke M, Copeland JR, Dartigues JF, Engedal K, Hagnell O, Heeren TJ: The prevalence of vascular dementia in Europe: Facts and fragment from 1980-1990 studies. Ann Neurol 1991;30:817-824.
11. Ueda K, Kawano H, Hasuo Y, Fujishima M: Prevalence and etiology of dementia in a Japanese community. Stroke 1992;23:798-803.
12. Kotsoris H, Barclay LL, Kheyferts S, Hulyalkar A, Dougherty J: Urinary and gait disturbances as markers for early multi-infarct dementia. J Neurol Neurosurg Psychiatry 1988;1:138-141.
13. Ratcliffe PJ, Wilcock GK: Cerebrovascular disease in dementia: The importance of atrial fibrillation. Postgrad Med J 1985;61:201-204.
14. McKhann G, Drachman DA, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA Work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
15. Van Duijn CM, Hofman A: Relation between nicotine intake and Alzheimer's disease. BMJ 1991;302:1491-1494.
16. Brenner DE, Kukull WA, van Belle G, Bowen JD, McCormick WC, Teri L, Larson EB: Relationship between cigarette smoking and Alzheimer's disease in a population-based case-control study. Neurology 1993;43:293-300.
17. Kokmen E, Beard CM, Chandra V, Offord KP, Schoenberg BS, Ballard DJ: Clinical risk factors for Alzheimer's disease: A population based cased-control study. Neurology 1991;41: 1393-1397.
18. Landin K, Blennow K, Wallin A, Gottfries C: Low blood pressure and blood glucose levels in Alzheimer's disease: Evidence for a hypometabolic disorder? J Intern Med 1993;233:357-362.
19. Prince MJ, Cullen MC, Mann A: Risk factors for Alzheimer's disease and dementia: A case-control study based on the MRC elderly hypertension trial. Neurology 1994;4:97-104.
20. Guo Z, Viitanen M, Fratiglioni L, Winblad B: Low blood pressure and dementia in elderly people: The Kungsholmen project. BMJ 1996; 312:805-808.
21. Kokmen E, Whisnant JP, O'Fallon WM, Chu CP, Beard CM: Dementia after ischemic stroke: A population-based study in Rochester, Minnesota (1960-1984). Neurology 1996;46: 154-159.
22. Censori B, Manara O, Agostinis C, Camerlingo M, Casot L, Galavotti B, Partziguian T, Servali MC, Cesana B, Belloni G, Mamoli A: Dementia after first stroke. Stroke 1996;27:1205-1210.
23. Tatemichi TK, Foulkes MA, Mohr JP, Hewitt JR, Hier DB, Price TR, Wolf PA: Dementia in stroke survivors in the stroke databank cohort. Prevalence, incidence, risk factors, and computed tomographic findings. Stroke 1990;21: 858-866.
24. Andersen G, Vestergaard K, Ostergaard Riis J, Ingeman-Nielsen M: Intellectual impairment in the first year following stroke, compared to an age-matched population sample. Cerebrovasc Dis 1996;6:363-369.
25. Skoog I, Nilsson L, Palmertz B, Andreasson LA, Svanborg A: A population-based study of dementia in 85 year olds. N Engl J Med 1993; 328:153-158.
26. Loeb C, Gandolfo C, Croce R, Conti M: Dementia associated with lacunar infarction. Stroke 1992;23:1225-1229.
27. Tatemichi TK, Paik M, Bagiella E, Desmond DW, Stern Y, Sano M, Hauser WA, Mayeux R: Risk of dementia after stroke in a hospitalized cohort: Results of a longitudinal study. Neurology 1994;44:1885-1891.
28. Henon H, Pasquier F, Durieu I, Godefroy O, Lucas C, Lebert F, Leys D: Preexisting dementia in stroke patients. Baseline frequency, associated factors, and outcome. Stroke 1997;28: 2429-2436.
29. Pasquier F, Leys D: Why are stroke patients prone to develop dementia? J Neurol 1997; 244:135-142.
30. Mortel KF, Meyer JS, Herod B, Thornby J: Education and occupation as risk factors for dementia of the Alzheimer and ischemic vascular types. Dementia 1995;6:55-62.
31. Prencipe M, Ferretti C, Casini AR, Santini M, Giubilei F, Culasso F: Stroke and dementia: Results of a population survey. Stroke 1997;28: 531-536.
32. Pohjasvaara T, Erkinjuntti T, Ylikoski R, Hietanen M, Vataja R, Kaste M: Clinical determinants of poststroke dementia. Stroke 1998;29: 75-81.
33. Gorelick PB, Brody J, Cohen D, et al: Risk factors for dementia associated with multiple cerebral infarcts. A case-control analysis in predominantly African-American hospital-based patients. Arch Neurol 1993;50:714-720.
34. Katzman R, Kawas C: The epidemiology of dementia and Alzheimer's disease; in Katzman R, Bick KL (eds): Alzheimer Disease. New York, Raven, 1994, pp 105-122.
35. Verhey FRJ, Lodder J, Rozendaal N, Jolles J: Comparison of seven sets of criteria used for the diagnosis of vascular dementia. Neuroepidemiology 1996;15:166-172.
36. Pantoni L, Inzitari D: Hachinski's Ischemic Score and the diagnosis of vascular dementia: A review. Ital J Neurol Sci 1993;14:539-546.
37. Gold G, Giannakopoulos P, Montes-Paixao C, Herrmann FR, Mulligan R, Michel JP, Bouras C: Sensitivity and specificity of newly proposed criteria for the diagnosis of possible vascular dementia. Neurology 1997;49:690-694.
38. Liston EH, La Rue A: Clinical differentiation of primary degenerative and multi-infarct dementia: A critical review of the evidence. I. Clinical studies. Biol Psychiatry 1983;18: 1451-1465.
39. Liston EH, La Rue A: Clinical differentiation of primary degenerative and multi-infarct dementia: A critical review of the evidence. II. Pathological studies. Biol Psychiatry 1983;18: 1467-1484.
40. Moroney JT, Bagiella E, Desmond DW, et al: Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias. Neurology 1997;49:1096-1105.
41. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A: Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980;7:486-488.
42. Loeb C, Gandolfo C: Diagnostic evaluation of degenerative and vascular dementia. Stroke 1983;14:399-401.
43. World Health Organization: The ICD-10 Classification of Mental and Behavioral Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva, World Health Oganization, 1992, pp 50-51.
44. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
45. Wetterling T, Danitz RD, Borgis KJ: The ICD-10 criteria for vascular dementia. Dementia 1994;5:185-188.
46. Pohjasvaara T, Erkinjuntti T, Vataja R, Kaste M: Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke 1997:28: 785-792.
47. Erkinjuntti T, Ostbye T, Steenhuis R, Hachinski V: The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med 1997;337:1667-1674.
48. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R: Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992;42:473-480.
49. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, Moody DM, O'Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fischer M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Scheinberg P: Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-259.
50. Amar K Wilcock GK, Scott M: The diagnosis of vascular dementia in the light of the new criteria. Age Ageing 1996;25:51-55.
51. Fornarelli D, Ascoli G, Rossi R, Manca A, Lanza R, Moretti V, Scarpino O, Guidi M: Clinical and instrumental diagnosis of Alzheimer's and multi-infarct dementia. Radiol Med 1996;92: 22-27.
52. Loeb C, Meyer JS: Vascular dementia: Still a debatable entity? J Neurol Sci 1996;143:31-40.
53. Meyer JS, Shirai T, Akiyama H: Neuroimaging for differentiating vascular from Alzheimer's dementias. Cerebrovasc Brain Metab Rev 1996;8:1-10.
54. Frisoni GB, Beltramello A, Binetti G, Bianchetti A, Weiss C, Scuratti A, Trabucchi M: Computed tomography in the detection of the vascular component in dementia. Gerontology 1995;41:121-128.
55. Charletta D, Gorelick PB, Dollear TJ, Freels S, Harris Y: CT and MRI findings among African-Americans with Alzheimer's disease, vascular dementia, and stroke without dementia. Neurology 1995;45:1456-1461.
56. Schmidt R: Comparison of magnetic resonance imaging in Alzheimer's disease, vascular dementia and normal aging. Eur Neurol 1992;32: 164-169.
57. Pullicino P, Benedict RH, Capruso DX, Vella N, Withiam-Leitch S, Kwen PL: Neuroimaging criteria for vascular dementia. Arch Neurol 1996;53:723-728.
58. Laakso MP, Partanen K, Riekkinen P, Lehtovirta M, Helkala EL, Hallikainen M, Hanninen T, Vainio P, Soininen H: Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study. Neurology 1996; 46:678-681.
59. Englund E, Brun A, Alling C: White matter changes in dementia of Alzheimer's type. Brain 1988;111:1425-1439.
60. Skoog I, Palmertz B, Andreasson LA: The prevalence of white matter lesions on computed tomography of the brain in demented and non-demented 85-year olds. J Geriatr Psychiatry Neurol 1994;7:169-175.
61. O'Brien J, Desmond P, Ames D, Schweitzer I, Harrigan S, Tress B: A magnetic resonance imaging study of white matter lesions in depression and Alzheimer's disease. Br J Psychiatry 1996;168:477-485.
62. Bennett DA, Gilley DW, Lee S, Cochran EJ: White matter changes: Neurobehavioral manifestations of Binswanger's disease and clinical correlates in Alzheimer's disease. Dementia 1994;5:148-152.
63. Meyer JS, Kawamura J, Terayama Y: White matter lesions in the elderly. J Neurol Sci 1992; 110:1-7.
64. Lechner H, Niederkorn K, Schmidt R: Does cerebrovascular insufficiency contribute to Alzheimer's disease? Ann N Y Acad Sci 1991; 640:74-79.
65. Obara K, Meyer JS, Mortel KF, Muramatsu K: Cognitive declines correlated with decreased cortical volume and perfusion in dementia of Alzheimer's type. J Neurol Sci 1994;127:96-102.
66. Meyer JS, Obara K, Muramatsu K, Mortel KF, Shirai T: Cognitive performance after small strokes correlates with ischemia not atrophy of the brain. Dementia 1995;6:312-322.
67. Giannakopoulos P, Hof PR, Mottier S, Michel JP, Bouras C: Neuropathological changes in the cerebral cortex of 1258 cases from a geriatric hospital: Retrospective clinicopathological evaluation of a 10-year autopsy population. Acta Neuropathol 1994;87:456-468.
68. Hof PR, Bierer LM, Perl DP, Delacourte A, Buée L, Bouras C, Morrison JH: Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-year-old patient with preclinical signs of dementia: Regional and laminar distribution on neurofibrillary tangles and senile plaques. Arch Neurol 1992;49:946-953.
69. Bouras C, Hof PR, Giannakopoulos P, Michel JP, Morrison JH: Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: A quantitative evaluation of a one-year autopsy population. Cereb Cortex 1994;4:138-150.
70. Arriagada PV, Growdon JH, Hedley-Whyte T, Hyman BT: Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992;42:631-639.
71. Price JL, Davis PB, Morris JC, White DL: The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging 1991;12:295-312.
72. Bierer LM, Hof PR, Purohit DP, Carlin L, Schmeidler J, Davis KL, Perl DP: Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch Neurol 1995;52:81-88.
73. Eberling JL, Jagust WJ, Reed BR, Baker MG: Reduced temporal lobe blood flow in Alzheimer's disease. Neurobiol Aging 1992;13:483-491.
74. Harris GJ, Lewis RF, Satlin A, English CD, Scott TM, Yurgelun-Todd DA, Renshaw PF: Dynamic susceptibility contrast MRI of regional cerebral blood volume in Alzheimer's disease. Am J Psychiatry 1996;153:721-724.
75. Wolfe N, Reed BR, Eberling JL, Jagust WJ: Temporal lobe perfusion on single photon emission tomography predicts the rate of cognitive decline in Alzheimer's disease. Arch Neurol 1995;52:257-262.
76. Johansson BB: Vascular mechanisms in hypertensive cerebrovascular disease. J Cardiovasc Pharmacol 1992;19:S11-S15.
77. 2 reactivity in the rat. Gerontology 1995;41:11-17.
78. Judd BW, Meyer JS, Rogers RL, Gandhi S, Tanahashi N, Mortel KF, Tawaklna T: Cognitive performance correlates with cerebrovascular impairments in multi-infarct dementia. J Am Geriatr Soc 1986;34:355-360.
79. Deutsch G, Tweedy JR: Cerebral blood flow in severity matched Alzheimer and multi-infarct patients. Neurology 1987;37:431-438.
80. Mielke R, Pietrzyk U, Jacobs A, Fink GR, Ichimaya A, Kessler J, Herholz K, Keiss WD: HMPAO SPECT and PET in Alzheimer's disease and vascular dementia: Comparison of perfusion and metabolic pattern. Eur J Nucl Med 1994;21:1052-1060.
81. Starkstein SE, Sabe L, Vazquez S, Teston A, Petracca G, Chemerinski E, Di Lorenzo G, Leiguarda R: Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease. Stroke 1996;27: 408-414.
82. Masterman DL, Mendez MF, Fairbanks LA, Cummings JL: Sensitivity, specificity, and positive predictive value of technetium 99-HMPAO SPECT in discriminating Alzheimer's disease from other dementias. J Geriatr Psychiatry Neurol 1997;10:15-21.
83. De Leon MJ, Ferris SH, George AE, Reisberg B, Christman DR, Kricheff II, Wolf AP: Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's disease. J Cereb Blood Flow Metab 1983;3:391-394.
84. McGeer PL, Kamo H, Harrop P, McGeer EG, Martin WRW, Pate BD, Li DKB: Comparison of PET, MRI and CT with pathology in a proven case of Alzheimer's disease. Neurology 1986;36:1569-1574.
85. Smith GS, De Leon MJ, George AE, Kliyer A, Volkow ND, McRae T, Golomb J, Ferris SH, Reisberg B, Garavino J, La Regina ME: Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Arch Neurol 1992;49:1142-1150.
86. Rapport SI: Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: A critical review. Cerebrovasc Brain Metab Rev 1991;3:297-335.
87. Polinsky RJ, Noble H, DiChiro G: Dominantly inherited Alzheimer's disease: Cerebral glucose metabolism. J Neurol Neurosurg Psychiatry 1987;50:752-757.
88. Jagust WJ, Friedland RP, Budinger TF: Longitudinal studies of regional cerebral metabolism in Alzheimer's disease. Neurology 1988;38: 909-912.
89. Jagust WJ, Eberling JL, Richardson BC, Reed BR, Baker MG, Nordahl TE, Budinger TF: The cortical topography of temporal lobe hypometabolism in early Alzheimer's disease. Brain Res 1993;629:189-198.
90. Mielke R, Schröder R, Fink GR, Kessler J, Herholz K, Heiss WD: Regional cerebral glucose metabolism and postmortem pathology in Alzheimer's disease. Acta Neuropathol 1996; 91:174-179.
91. Frackowiak RSJ, Pozzilli C, Legg NJ, Du Boulay GH, Marshall J, Lenzi GL, Jones T: Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain 1981;104:753-778.
92. Hoyer S: Senile dementia and Alzheimer's disease, brain blood flow and metabolism. Prog Neuropsychopharmacol Biol Psychiatry 1986; 10:447-478.
93. Herholz K: FDG PET and differential diagnosis of dementia. Alzheimer Dis Assoc Disord 1995;9:6-16.
94. Heiss WD, Kessler J, Szelies B, Grond M, Fink G, Herholz K: Positron emission tomography in the differential diagnosis of organic dementias. J Neural Transm Suppl 1991;33: 13-19.
95. Harik SI, Kalaria RN: Blood-brain barrier abnormalities in Alzheimer's disease. Ann NY Acad Sci 1991;640:47-52.
96. Simpson IA, Chundu KR, Davies-Hill T, Honer WG, Davies P: Decreased concentration of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease. Ann Neurol 1994;35:546-551.
97. Blass JP: Pathophysiology of the Alzheimer's syndrome. Neurology 1993;43:S25-S38.
98. Meier-Ruge W, Bertoni-Freddari C: The significance of glucose turnover in the brain in the pathogenetic mechanisms of Alzheimer's disease. Rev Neurosci 1996;7:1-19.
99. Malamud N, Grosh LC: Hyperinsulinism and cerebral change. Arch Intern Med 1998;61: 579-582.
100. Jendroska K, Poewe W, Kaniel SE, Pluess J, Iwerssen-Schmidt H, Paulsen J, Barthel S, Schelosky L, Cervos-Navarro J, DeArmond SJ: Ischemic stress induces deposition of amyloid β immunoreactivity in human brain. Acta Neuropathol 1995;90:461-466.
101. Sparks DL: Intraneuronal β-amyloid immunoreactivity in the CNS. Neurobiol Aging 1996;17:291-299.
102. Mandybur TI: The incidence of cerebral amyloid angiopathy in Alzheimer's disease. Neurology 1975;25:120-126.
103. Kawai M, Kalaria RN, Cras P, Siedlak SL, Velasco ME, Shelton ER, Chan HW, Greenberg BD, Perry G: Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease. Brain Res 1993;623: 142-146.
104. Vinters HV, Seeor DL, Read SL, Frazee JG, Tomiyasu U, Stanley TM, Ferreiro JA, Akers M-A: Microvasculature in brain biopsy specimens from patients with Alzheimer's disease: An immunohistochemical and ultrastructural study. Ultrastruct Pathol 1994;18:333-348.
105. Perlmutter LS: Microvascular pathology and vascular basement membrane components in Alzheimer's disease. Mol Neurobiol 1994;9: 33-40.
106. Roher AE, Lowenson GD, Clarke S, Woods AS, Cotter RJ, Gowing E, Ball MJ: β-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: Implications for the pathology of Alzheimer disease. Proc Natl Acad Sci USA 1993;90:10836-10840.
107. Shinkai Y, Yoshimura M, Ito Y, Odaka A, Suzuki N, Yanagisawa K, Ihara Y: Amyloid β-protein 1-40 and 1-42(43) in the soluble fraction of extra- and intracranial blood vessels. Ann Neurol 1995;38:421-428.
108. Gravina SA, Ho L, Eckman CB, Long KE, Otvos L Jr, Younkin LH, Suzuki N, Younkin SG: Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43). J Biol Chem 1995;270:7013-7016.
109. Joachim CL, Morris JH, Selkoe DJ: Clinically diagnosed Alzheimer's disease: Autopsy results in 150 cases. Ann Neurol 1988;24:50-56.
110. Zlokovic BV, Ghiso J, Mackic JB, McComb JG, Weiss MH, Frangione B: Blood-brain barrier transport of circulating Alzheimer's amyloid beta. Biochem Biophys Res Commun 1993;197:1034-1040.
111. Lippa CF, Hamos JE, Smith TW, Pulaski-Salo D, Drachman DA: Vascular amyloid deposition in Alzheimer's disease. Neither necessary nor sufficient for the local formation of plaques and tangles. Arch Neurol 1993;50: 1088-1092.
112. Banati RB, Schubert P, Rothe G, Gehrmann J, Rudolphi K, Valet G, Kreutzberg GW: Modulation of intracellular formation of reactive oxygen intermediates in peritoneal macrophages and microglia/brain macrophages by propentofylline. J Cereb Blood Flow Metab 1994;14:145-149.
113. Wisniewski HM, Wegiel J: β-Amyloid formation by myocytes of leptomeningeal vessels. Acta Neuropathol 1994;87:233-241.
114. Frautchy SA, Cole GM, Baird A: Phagocytosis and deposition of vascular β-amyloid in rat brains injected with Alzheimer β-amyloid. Am J Pathol 1992;140:1389-1399.
115. Fischer VW, Siddiqi A, Yusufaly Y: Altered angioarchitecture in selected areas of brains with Alzheimer's disease. Acta Neuropathol 1990;79:672-667.
116. Buée L, Hof PR, Bouras C, Delacourte A, Perl DP, Morrison JH, Fillit HM: Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol 1994;87:469-480.
117. Bell MA, Ball MJ: Neuritic plaques and vessels of visual cortex in aging and Alzheimer's dementia. Neurobiol Aging 1990;11:359-370.
118. Scheibel AB, Duong T, Tomiyasu U: Denervation microangiopathy in senile dementia, Alzheimer type. Alzheimer Dis Assoc Disord 1987;1:19-37.
119. Wisniewski HM, Wegiel J, Wang KC, Lach B: Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease. Acta Neuropathol 1992;84: 117-127.
120. Stewart PA, Hayakawa K, Akers MA, Vinters HV: A morphometric study of the blood-brain barrier in Alzheimer's disease. Lab Invest 1992;67:734-742.
121. De la Torre JC: Impaired brain microcirculation may trigger Alzheimer's disease. Neurosci Biobehav Res 1994;18:397-401.
122. De la Torre JC, Mussivand T: Can disturbed brain microcirculation cause Alzheimer's disease? Neurol Res 1993;15:146-153.
123. Bell MA, Ball MJ: Morphometric comparison of hippocampal microvasculature in ageing and demented people: Diameters and densities. Acta Neuropathol 1981;53:299-318.
124. Kalaria RN, Hedera P: Differential degeneration of the cerebral microvasculature in Alzheimer's disease. Neuroreport 1995;6:477-480.
125. Claudio L: Ultrastructural features of the blood-brain barrier in biopsy tissue from Alzheimer's disease patients. Acta Neuropathol 1996;91:6-14.
126. Mueller SM, Luft FC: The blood-brain barrier in renovascular hypertension. Stroke 1982;13:229-234.
127. Caceres MJ, Schleien CL, Kuluz JW, Gelman B, Dietrich WD: Early endothelial damage and leukocyte accumulation in piglet brains following cardiac arrest. Acta Neuropathol 1995;90:582-591.
128. Blanc EM, Toborek M, Mark RJ, Hennig B, Mattson MP: Amyloid beta-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. J Neurochem 1997;68:1870-1881.
129. Grammas P, Botchlet T, Fugate R, Ball MJ, Roher AE: Alzheimer disease amyloid proteins inhibit brain endothelial cells proliferation in vitro. Dementia 1995;6:126-130.
130. Thomas T, Thomas G, McLcndon C, Sutton T, Mullan M: Beta-amyloid-mediated vasoactivity and vascular endothelial damage. Nature 1996;380:168-171.
131. Suo Z, Fang C, Crawford F, Mullan M: Superoxide free radical and intracellular calcium mediate A beta(1-42) induced endothelial toxicity. Brain Res 1997;762:144-152.
132. Kumar M, Liu GJ, Floyd RA, Grammas P: Anoxic injury of endothelial cells increases production of nitric oxide and hydroxyl radicals. Biochem Biophys Res Commun 1996; 219:497-501.
133. Pereira HA, Kumar P, Grammas P: Expression of CAP37, a novel inflammatory mediator, in Alzheimer's disease. Neurobiol Aging 1996;17:753-759.
134. Wisniewski HM, Kozolowski PB: Evidence for blood-brain barrier changes in senile dementia of Alzheimer's type (AD/SDAT), Alzheimer's disease, Down's syndrome and aging. Ann NY Acad Sci 1982;396:119-129.
135. Alafuzoff I, Adolfsson R, Grundke-Iqbal I, Winblad B: Blood-brain barrier in Alzheimer dementia and in non-demented elderly. Acta Neuropathol 1987;73:160-166.
136. Slemmon JR, Hughes CM, Campbell GA, Flood DG: Increased levels of hemoglobin-derived and other peptides in Alzheimer's disease cerebellum. J Neurosci 1994;14: 2225-2235.
137. Blennow K, Wallin A, Fredman P, Karlsson I, Gottfries CG, Svennerholm L: Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors. Acta Neurol Scand 1990;81:323-326.
138. Friedland RP, Jagust WJ, Huesman RH, Koss E, Knittel B, Mathis CA, Ober BA, Mazoyer BM, Budinger TF: Regional cerebral glucose transport and utilization in Alzheimer's disease. Neurology 1989;39:1427-1434.
139. Mecocci P, Parnetti L, Reboldi GP, Santucci C, Gaiti A, Ferri C, Germini I, Romagnoli M, Cadini D, Senin U: Blood-brain barrier in a geriatric population: Barrier function in degenerative and vascular dementias. Acta Neurol Scand 1991;84:210-213.
140. Vorbrodt AW, Dobrogowska DH, Tarnawski M, Meeker HC, Carp RI: Immunocytochemical evaluation of blood-brain barrier to endogenous albumin in scrapie-infected mice. Acta Neuropathol 1997;93:341-348.